Investigation Overview
February 5, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Alere Inc (NYSE:ALR), was announced concerning whether the takeover of Alere Inc by Abbott is unfair to NYSE:ALR stockholders.
The investigation by a law firm concerns whether certain officers and directors of Alere Inc breached their fiduciary duties owed to (NYSE:ALR investors in connection with the proposed acquisition.
On February 1, 2016, Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced an agreement for Abbott to acquire Alere. Under the terms of the agreement, Abbott will pay $56 per common share at a total expected equity value of $5.8 billion.
However, given that at least one analyst has set the high target price for NYSE:ALR shares at $60.00 per share, the investigation concerns whether the offer is unfair to NYSE:ALR stockholders. More specifically, the investigation concerns whether the Alere Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.